Source: Contract Pharma

Genalyte: Genalyte Launches High-Speed COVID-19 Antibody Test

First instrument-based, rapid test uses multi-antigen approach; U.S. FDA EUA submitted

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

CEO

Ashraf Hanna

CEO Approval Rating

82/100

Genalyte is a life science company that provides clinical diagnostic and testing solutions for physicians and healthcare sectors.